This federal contract award, with ID SPE2DB20D1110|SPE2DB25FJ85D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $13,131.69, is for the delivery of 500 tablets of 4 mg Ondansetron HCL, a medication used to prevent nausea and vomiting.
The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of December 31, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/31/25, 9:33 AM